registration by country
- Select a country -
Czech and Slovak Reps
Denmark
France
Germany
Greece
Iceland
Italy
Norway
Poland
Portugal
Spain
Turkey
United Kingdom
home
What is NAVELBINE®?
True or false ideas about chemotherapy
How to use it?
Adverse effects and what to do?
Product caracteristics
Pharmaceutical form
Administration
Navelbine® Oral or Navelbine® Who and Why?
Adverse effects
History
Oncologie research
Busilvex
®
print
T
+
T-
Navelbine® and the patient
What is NAVELBINE®?
True or false ideas about chemotherapy
Oral chemotherapy: What is it?
Oral chemotherapy: Is it effective?
Tolerance with oral chemotherapy
Monitoring oral chemotherapy
Oral chemotherapy and reduced constraints
How to use it?
Adverse effects and what to do?
Navelbine® and the health professional
Product caracteristics
Pharmaceutical form
Administration
How to use it?
Number of capsules to be taken per administration
Navelbine® Oral or Navelbine® Who and Why?
Adverse effects
Pierre Fabre Oncologie
History
Oncologie research
Registration by country
Czech and Slovak Reps
Denmark
France
Germany
Greece
Iceland
Italy
Norway
Poland
Portugal
Spain
Turkey
United Kingdom
Cancer Links
Cancer links
Pierre Fabre
Group Sites
Site map
|
Terms and conditions
|
Credits
